XXXXXXXXX XXXXXXXX XXXXXX (XX) 2024/221
ze xxx 12.&xxxx;xxxxx 2024
x&xxxx;xxxxxxxx xxxxxxxx xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxx, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx reesei XXXX 74444&xxxx;xxxx xxxxxxxxx xxxxx xxx xxxxx xxxxx xxxxx drůbeže, xxxxxxx xxxxx drůbeže xxxxxx xx xxxxxx x&xxxx;xxxxxxxxx xxxxxx (držitel xxxxxxxx: DSM Nutritional Xxxxxxxx) x&xxxx;x&xxxx;xxxxx xxxxxxxxxxx xxxxxxxx (EU) x.&xxxx;403/2013
(Xxxx x&xxxx;xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,
x&xxxx;xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1831/2003 xx dne 22.&xxxx;xxxx&xxxx;2003 o doplňkových xxxxxxx xxxxxxxxxxx xx xxxxxx xxxxxx&xxxx;(1), a zejména xx xx.&xxxx;9 xxxx.&xxxx;2 xxxxxxxxx xxxxxxxx,
xxxxxxxx x&xxxx;xxxxx xxxxxxx:
|
(1) |
Xxxxxxxx (XX) x.&xxxx;1831/2003 xxxxxxx xxxxxxxx doplňkových xxxxx xxxxxxxxxxx xx xxxxxx xxxxxx x&xxxx;xxxxxx a postupy, xx jejichž xxxxxxx xx xxxxxxxx xxxxxxx x&xxxx;xxxxxxxx. |
|
(2) |
Xxxxxxxxx z endo–1,4-beta-xylanázy, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx XXXX 74444 xxx xxxxxxx xx xxxxx xxx xxxx doplňková xxxxx xxx výkrm xxxxxxx, xxxxxxx x&xxxx;xxx xxxxxxxxx selata xxxxxxxxxx xxxxxxxxx Xxxxxx (XX) x.&xxxx;403/2013&xxxx;(2). |
|
(3) |
X&xxxx;xxxxxxx s čl. 14 xxxx.&xxxx;1 xxxxxxxx (ES) x.&xxxx;1831/2003 xxxx podána žádost x&xxxx;xxxxxxxx povolení xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxx, endo–1,3(4)-beta-glukanázy x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx ATCC 74444&xxxx;xxxx xxxxxxxxx xxxxx. Xxxxxxx xxxxxx xxxx xxxxxx xxxxx s údaji x&xxxx;xxxxxxxxx xxxxxxxxxxxx xxxxx xx.&xxxx;14 xxxx.&xxxx;2 xxxxxxxx (XX) x.&xxxx;1831/2003. |
|
(4) |
Xxxxxxxx úřad xxx xxxxxxxxxx potravin (xxxx xxx „xxxx“) xxxxxx ve xxxx xxxxxxxxxx ze dne 11.&xxxx;xxxxxx&xxxx;2023&xxxx;(3) x&xxxx;xxxxxx, xx xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxx, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx z Trichoderma reesei XXXX 74444 xx xx stávajících xxxxxxxxxx xxxxxxxx xxxxxxx i nadále xxxxxxxx xxx xxxxx xxxxxxx, nosnice x&xxxx;xxx xxxxxxxxx xxxxxx, xxxxxxxxxxxx x&xxxx;xxxxxxx xxxxxxxxx. Úřad xxxxxx xxxxxx x&xxxx;xxxxxx, xx přípravek z endo–1,4-beta-xylanázy, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx XXXX 74444 xx měl xxx xxxxxxxxx xx xxxxx xxxxxxxxxxx senzibilizující dýchací xxxxx. Xxxxxxxx x&xxxx;xxxx, xx xxxxxx k dispozici xxxxx, nebyl xxxx xxxxxxx xxxxxxx závěr xxxxxxx potenciálu xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx xxxx a očí xxxx xxxxxxxxxxxxx xxxx. Úřad xxxxxx uvedl, xx x&xxxx;xxxxxxxxxxx s obnovením xxxxxxxx xxxx xxxxx posuzovat xxxxxxxx xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxx, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx XXXX 74444. Xxxx nepovažoval xxxxxxxx xxxxxxxxx na xxxxxxxxxxxx xx uvedení xx xxx za nutné. Xxxx xxxx xxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxxxxx xxxxx xxxxxxx xx xxxxx předloženou xxxxxxxxxx laboratoří, xxxxxxxx xxxxxxxxx (ES) x.&xxxx;1831/2003. |
|
(5) |
Xxxxxxxx x&xxxx;xxxx xxxxxxxx xxxxxxxxxxxx xx Xxxxxx xxxxxxx, xx přípravek z endo–1,4-beta-xylanázy, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx z Trichoderma xxxxxx ATCC 74444 xxxxxxx xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx&xxxx;5 xxxxxxxx (ES) x.&xxxx;1831/2003. Xxxxx xx xxxxxxxx uvedené xxxxxxxxx xxxxx xxxx xxx xxxxxxxx. Xxxxx xxxx xx Xxxxxx xxxxxxx, xx by xxxx xxx přijata xxxxxx xxxxxxxx xxxxxxxx, xxx xx zabránilo xxxxxxxxxxx xxxxxxx xx zdraví xxxxxxxxx dané xxxxxxxxx xxxxx. |
|
(6) |
X&xxxx;xxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx z endo–1,4-beta-xylanázy, endo–1,3(4)-beta-glukanázy x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx XXXX 74444 jako xxxxxxxxx xxxxx by xxxx xxx xxxxxxx xxxxxxxxx xxxxxxxx (EU) č. 403/2013. |
|
(7) |
Vzhledem x&xxxx;xxxx, xx bezpečnostní xxxxxx nevyžadují xxxxxxxx xxxxxxxxx změn v podmínkách xxx xxxxxxxx xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxx, endo–1,3(4)-beta-glukanázy x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx reesei XXXX 74444, je xxxxxx xxxxxxxx xxxxxxxxx xxxxxx, xxxxx xx xxxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx xx xx xxxxxx xxxxxx xxxxxxxxx xxxxxxxxxxxxx x&xxxx;xxxxxxxx povolení. |
|
(8) |
Opatření xxxxxxxxx xxxxx xxxxxxxxx xxxx x&xxxx;xxxxxxx xx xxxxxxxxxxx Xxxxxxx xxxxxx pro xxxxxxxx, zvířata, xxxxxxxxx x&xxxx;xxxxxx, |
XXXXXXX TOTO XXXXXXXX:
Xxxxxx&xxxx;1
Xxxxxxxx xxxxxxxx
Xxxxxxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxx, xxxxxxxxxxxx xx xxxxxxxxx doplňkových xxxxx „zootechnické xxxxxxxxx xxxxx“ x&xxxx;xxxxxxx xxxxxxx „xxxxx zvyšující xxxxxxxxxxxxx“, xx obnovuje xxxxx xxxxxxxx stanovených v uvedené xxxxxxx.
Xxxxxx&xxxx;2
Xxxxx prováděcího xxxxxxxx (XX) č. 403/2013
Prováděcí xxxxxxxx (XX) x.&xxxx;403/2013 se xxxx xxxxx:
|
1. |
xxxxxx&xxxx;1 xx xxxxxxx; |
|
2. |
xxxxxxx se xxxxxxx. |
Xxxxxx&xxxx;3
Xxxxxxxxx xxxxxxxx
1.&xxxx;&xxxx;&xxxx;Xxxxxxxxx xxxxxxx x&xxxx;xxxxxxx a premixy obsahující xxxxx přípravek, xxxxxxxx x&xxxx;xxxxxxxx xxxx xxxx 4.&xxxx;xxxxx 2024 x&xxxx;xxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx xxxx 4. února 2024, xxxxx xxx xxxxxx xxxxxxx xx xxx x&xxxx;xxxxxxxxx až xx xxxxxxxxx xxxxxxxxxxx zásob.
2. Krmné xxxxx x&xxxx;xxxxx suroviny xxxxxxxxxx xxxxxxxxx xxxxxxx x&xxxx;xxxxxxx, xxxxxxxx a označené xxxx 4. xxxxxx 2025 x&xxxx;xxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx 4. xxxxxx 2024, xxxxx xxx xxxxxxx na xxx a používány xx xx xxxxxxxxx xxxxxxxxxxx xxxxx.
Xxxxxx&xxxx;4
Xxxxx x&xxxx;xxxxxxxx
Xxxx nařízení xxxxxxxx v platnost xxxxxxxx xxxx xx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.
Xxxx xxxxxxxx je xxxxxxx x&xxxx;xxxxx rozsahu x&xxxx;xxxxx použitelné ve xxxxx členských xxxxxxx.
X&xxxx;Xxxxxxx xxx 12.&xxxx;xxxxx 2024.
Xx Xxxxxx
xxxxxxxxxxx
Xxxxxx XXX XXX XXXXX
(1)&xxxx;&xxxx; Xx.&xxxx;xxxx.&xxxx;X&xxxx;268, 18.10.2003, x.&xxxx;29.
(2)&xxxx;&xxxx;Xxxxxxxxx nařízení Xxxxxx (XX) x.&xxxx;403/2013 xx xxx 2.&xxxx;xxxxxx&xxxx;2013 o povolení xxxxxxxxx z endo–1,4-beta-xylanázy, xxxx–1,3(4)-xxxx-xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx (XXXX 74444) xxxx xxxxxxxxx xxxxx xxx xxxxx drůbeže, xxxxxxx x&xxxx;xxx odstavená selata x&xxxx;xxxxxx xx mění xxxxxxxx (XX) x.&xxxx;1259/2004, (XX) x.&xxxx;1206/2005 a (ES) x.&xxxx;1876/2006 (držitel xxxxxxxx XXX Xxxxxxxxxxx Xxxxxxxx) (Xx.&xxxx;xxxx.&xxxx;X&xxxx;121, 3.5.2013, x.&xxxx;26).
(3)&xxxx;&xxxx; XXXX Xxxxxxx 2023;21(6):8043.
PŘÍLOHA
|
Identifikační číslo doplňkové xxxxx |
Xxxxx xxxxxxxx povolení |
Doplňková xxxxx |
Xxxxxxx, xxxxxxxx xxxxxx, xxxxx, analytická xxxxxx |
Xxxx xxxx xxxxxxxxx xxxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxxxx obsah |
Maximální xxxxx |
Xxxx xxxxxxxxxx |
Xxxxx xxxxxxxxx xxxxxxxx |
||||||||||||||||||||||
|
Xxxxxxxx xxxxxxxx/xx xxxxxxxxxxx xxxxxx x&xxxx;xxxxxx vlhkosti 12 % |
|||||||||||||||||||||||||||||||
|
Kategorie: xxxxxxxxxxxx xxxxxxxxx xxxxx. Xxxxxxx skupina: látky xxxxxxxxx stravitelnost. |
|||||||||||||||||||||||||||||||
|
4a1602i |
DSM Nutritional Xxxxxxxx |
Xxxx–1,4-xxxx-xxxxxxxx (XX 3.2.1.8) Endo–1,3(4)-beta-glukanáza (ES 3.2.1.6) Xxxx–1,4-xxxx-xxxxxxxxx (XX 3.2.1.4) |
Xxxxxxx doplňkové xxxxx Xxxxxxxxx x&xxxx;xxxx–1,4-xxxx-xxxxxxxx, endo–1,3(4)-beta-glukanázy x&xxxx;xxxx–1,4-xxxx-xxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxx XXXX 74444 x&xxxx;xxxxxxx aktivity xxx:
Kapalná nebo xxxxx xxxxx. Xxxxxxxxxxxxxxx účinné xxxxx Xxxx–1,4-xxxx-xxxxxxxx (ES 3.2.1.8), xxxx–1,4-xxxx-xxxxxxxxx (ES 3.2.1.6) x&xxxx;xxxx–1,3(4)-xxxx-xxxxxxxxx (ES 3.2.1.4) x&xxxx;Xxxxxxxxxxx xxxxxx XXXX 74444 Xxxxxxxxxx metoda (4)
|
Xxxxx všech druhů xxxxxxx kromě xxxxxx xxxx |
— |
Xxxx–1,4-xxxx-xxxxxxxx: 135 X Xxxx–1,3(4)-xxxx-xxxxxxxxx: 35 X Xxxx–1,4-xxxx-xxxxxxxxx: 40 X |
— |
|
4.&xxxx;xxxxx 2034 |
||||||||||||||||||||||
|
Xxxxxxx xxxxx xxxxxxx xxxxxx xx xxxxxx |
Xxxx–1,4-xxxx-xxxxxxxx: 216 X Xxxx–1,3(4)-xxxx-xxxxxxxxx: 56 U Endo–1,4-beta-glukanáza: 64 X |
||||||||||||||||||||||||||||||
|
Xxxxx krůt Selata (xxxxxxxxx) |
Xxxx–1,4-xxxx-xxxxxxxx: 270 X Xxxx–1,3(4)-xxxx-xxxxxxxxx: 70 X Xxxx–1,4-xxxx-xxxxxxxxx: 80 U |
||||||||||||||||||||||||||||||
(1) Jedna xxxxxxxx (X) xxxx-1,4-xxxx-xxxxxxxx xx xxxxxxxx enzymu, xxxxx xxxxxx 1 xxxxxxxxx redukujícího xxxxx (xxxxxxxxxx xxxxxx) xx xxxxxx z pšeničného xxxxxxxxxxxxx xxx xxxxxxx 40&xxxx;°X&xxxx;x&xxxx;xX&xxxx;5,0.
(2)&xxxx;&xxxx;Xxxxx xxxxxxxx (X) xxxx-1,3(4)-xxxx-xxxxxxxxx xx xxxxxxxx xxxxxx, xxxxx xxxxxx 1 xxxxxxxxx xxxxxxxxxxxx xxxxx (xxxxxxxxxx glukózy) za xxxxxx x&xxxx;xxxxxxx xxxx-xxxxxxx xxx xxxxxxx 40&xxxx;°X&xxxx;x&xxxx;xX&xxxx;5,0.
(3)&xxxx;&xxxx;Xxxxx xxxxxxxx (U) xxxx-1,4-xxxx-xxxxxxxxx xx xxxxxxxx xxxxxx, xxxxx xxxxxx 1 xxxxxxxxx xxxxxxxxxxxx xxxxx (xxxxxxxxxx glukózy) za xxxxxx x&xxxx;xxxxxxxxxxxxxxxxxxxxx xxx xxxxxxx 40&xxxx;°X&xxxx;x&xxxx;xX&xxxx;5,0.
(4)&xxxx;&xxxx;Xxxxxxxx informace x&xxxx;xxxxxxxxxxxx metodách lze xxxxxx xx internetové xxxxxxx xxxxxxxxxx xxxxxxxxxx: xxxxx://xxxxx-xxxxxxxx-xxxxxx.xx.xxxxxx.xx/xxxx-xx-xxxx-xxxx-xxxxxxxxx/xxxx-xx-xxxxxxxxxxxxx/xxxx-xx-xxxxxxxxxx-xxxxxxx_xx.